Palm Tocotrienols in Chronic Hemodialysis (USA)

NACompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

August 31, 2020

Conditions
End Stage Renal DiseaseChronic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

TRF (Tocotrienol-rich-fraction)

2 x 150 mg capsules

DIETARY_SUPPLEMENT

Placebo

2 x 150 mg capsules

Trial Locations (1)

48202

Wayne State University, Detroit

All Listed Sponsors
collaborator

DaVita, Inc.

INDUSTRY

collaborator

Great Lakes Dialysis, LLC

OTHER

collaborator

National University of Malaysia

OTHER

collaborator

Universiti Putra Malaysia

OTHER

collaborator

Ministry of Health, Malaysia

OTHER_GOV

collaborator

National Kidney Foundation, United States

OTHER

collaborator

PEMANDU

UNKNOWN

collaborator

Henry Ford Hospital

OTHER

collaborator

Kidney Foundation Hospital and Research Institute, Bangladesh

OTHER

collaborator

Fortis Hospital, India

OTHER

lead

Wayne State University

OTHER

NCT02358967 - Palm Tocotrienols in Chronic Hemodialysis (USA) | Biotech Hunter | Biotech Hunter